Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review

Detalhes bibliográficos
Autor(a) principal: Pinto, João Moreira
Data de Publicação: 2011
Outros Autores: Rocha, Paula, Osório, Angélica, Bonet, Berta, Carvalho, Fátima, Duarte, Carlos, Oliveira, Luísa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/1822/18819
Resumo: Chylothorax is a well-recognized omplication after neonatal cardiothoracic surgery. Management strategies include cessation of enteral feedings, repeated aspiration, chest drainage, and total parenteral nutrition. Somatostatin and its analogue, octreotide, have been used with promising results. The authors present three cases of neonatal postoperative chylothorax in which ctreotide was used. After literature review, we can say that octreotide is relatively safe, and may reduce clinical course and complications associated with neonatal postoperative chylothorax. One should be aware of possible association between octreotide and necrotizing enterocolitis. Prospective controlled trials supporting octreotide use are lacking.
id RCAP_df81f06f48dd8fc7425340bfa4dba0ac
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/18819
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature reviewChylothoraxNewbornCongenital heart diseaseCongenital diaphragmatic herniaEsophageal atresiaOctreotideScience & TechnologyChylothorax is a well-recognized omplication after neonatal cardiothoracic surgery. Management strategies include cessation of enteral feedings, repeated aspiration, chest drainage, and total parenteral nutrition. Somatostatin and its analogue, octreotide, have been used with promising results. The authors present three cases of neonatal postoperative chylothorax in which ctreotide was used. After literature review, we can say that octreotide is relatively safe, and may reduce clinical course and complications associated with neonatal postoperative chylothorax. One should be aware of possible association between octreotide and necrotizing enterocolitis. Prospective controlled trials supporting octreotide use are lacking.Springer VerlagUniversidade do MinhoPinto, João MoreiraRocha, PaulaOsório, AngélicaBonet, BertaCarvalho, FátimaDuarte, CarlosOliveira, Luísa2011-082011-08-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/18819eng0179-035810.1007/s00383-010-2730-220821216http://www.springerlink.com/info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:04:30Zoai:repositorium.sdum.uminho.pt:1822/18819Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:54:49.441842Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
title Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
spellingShingle Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
Pinto, João Moreira
Chylothorax
Newborn
Congenital heart disease
Congenital diaphragmatic hernia
Esophageal atresia
Octreotide
Science & Technology
title_short Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
title_full Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
title_fullStr Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
title_full_unstemmed Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
title_sort Octreotide in the treatment of neonatal postoperative chylothorax : report of three cases and literature review
author Pinto, João Moreira
author_facet Pinto, João Moreira
Rocha, Paula
Osório, Angélica
Bonet, Berta
Carvalho, Fátima
Duarte, Carlos
Oliveira, Luísa
author_role author
author2 Rocha, Paula
Osório, Angélica
Bonet, Berta
Carvalho, Fátima
Duarte, Carlos
Oliveira, Luísa
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Pinto, João Moreira
Rocha, Paula
Osório, Angélica
Bonet, Berta
Carvalho, Fátima
Duarte, Carlos
Oliveira, Luísa
dc.subject.por.fl_str_mv Chylothorax
Newborn
Congenital heart disease
Congenital diaphragmatic hernia
Esophageal atresia
Octreotide
Science & Technology
topic Chylothorax
Newborn
Congenital heart disease
Congenital diaphragmatic hernia
Esophageal atresia
Octreotide
Science & Technology
description Chylothorax is a well-recognized omplication after neonatal cardiothoracic surgery. Management strategies include cessation of enteral feedings, repeated aspiration, chest drainage, and total parenteral nutrition. Somatostatin and its analogue, octreotide, have been used with promising results. The authors present three cases of neonatal postoperative chylothorax in which ctreotide was used. After literature review, we can say that octreotide is relatively safe, and may reduce clinical course and complications associated with neonatal postoperative chylothorax. One should be aware of possible association between octreotide and necrotizing enterocolitis. Prospective controlled trials supporting octreotide use are lacking.
publishDate 2011
dc.date.none.fl_str_mv 2011-08
2011-08-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/18819
url http://hdl.handle.net/1822/18819
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0179-0358
10.1007/s00383-010-2730-2
20821216
http://www.springerlink.com/
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer Verlag
publisher.none.fl_str_mv Springer Verlag
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132331974328320